" /> Yttrium Y-90 Clivatuzumab Tetraxetan - CISMeF





Preferred Label : Yttrium Y-90 Clivatuzumab Tetraxetan;

NCIt synonyms : 90Y-hPAM4; Yttrium Y 90 Clivatuzumab Tetraxetan; Yttrium (90Y) Clivatuzumab Tetraxetan;

NCIt related terms : yttrium Y 90 DOTA monoclonal antibody HuPAM4;

NCIt definition : A radioimmunoconjugate comprised of the humanized monoclonal antibody clivatuzumab, directed against the pancreatic cancer antigen MUC1, that is conjugated to the chelating agent tetraxetan and radiolabeled with the beta-emitting radioisotope Yttrium Y 90. Yttrium Y 90 clivatuzumab tetraxetan binds to tumor cells expressing MUC1 antigen, thereby selectively delivering a cytotoxic dose of beta radiation.;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of advanced pancreatic cancer. HuPAM4 is a monoclonal antibody that can locate and bind to pancreatic cancer cells. It is linked to a radioactive substance called yttrium Y90, which may help kill cancer cells. Yttrium Y 90 DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate.;

UNII : 2L271110ED;

CAS number : 943976-23-6;

Drug name : hPAM4-Cide;

Molecule name : hPAM4-DOTA; IMMU-107;

Chemical formula : C16H25N5O7.Y;

Codes from synonyms : CDR0000489307;

Details


You can consult :


Nous contacter.
31/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.